Atossa Therapeutics (ATOS) Earnings Analysis
Atossa Therapeutics (ATOS) next reports earnings on 2026-08-11, consensus EPS -1.04 USD. Last quarter (2026-05-08) it beat with EPS -1.11 USD vs -1.22 USD est (+9%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.56.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ATOS next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -1.04 USD |
| Revenue estimate | n/a |
ATOS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | -1.11 USD | -1.22 USD | +9% | Beat |
| 2026-03-25 | -1.19 USD | -1.1375 USD | -4.6% | Miss |
| 2025-11-12 | -1.05 USD | -1.05 USD | 0% | Beat |
| 2024-08-12 | -0.05 USD | -0.05 USD | 0% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
ATOS valuation and analyst view
| Trailing P/E | -0.56 |
|---|---|
| Trailing EPS | -4.36555 USD |
| Price / book | 0.69 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (4 buy / 1 hold / 0 sell) |
| Avg price target | 10 USD |
Related research pages
Frequently asked questions
When is Atossa Therapeutics (ATOS)'s next earnings date?
Atossa Therapeutics is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -1.04 USD.
Did ATOS beat earnings last quarter?
In its 2026-05-08 report, ATOS posted EPS of -1.11 USD versus a -1.22 USD estimate — a beat of 9%.
What is ATOS's earnings track record?
Over the last 4 reported quarters with consensus data, ATOS beat estimates 3 times (75%).
What is ATOS's current P/E ratio and EPS?
ATOS trades at a trailing P/E of -0.56 on trailing EPS of -4.3655460864278615 USD.
What do analysts rate ATOS?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 10 USD.